PROGRESS/ enzymes $2.48
Verenium and Novus International announce important progress in the development of novel enzymes for animal health & nutrition (VRNM) 2.48 : Co and Novus International announced significant steps forward in their collaboration's progress toward commercializing its suite of next-generation animal nutrition enzymes. The two companies, which entered into a strategic partnership in 2011, recently selected lead enzyme candidates for the development of the collaboration's suite of non-starch polysaccharide (NSP) products designed to enhance the digestibility of feedstuffs in monogastric diets. Additionally, the two companies announced that their next-generation phytase remains on track and the commercial launch of the product into select geographies is targeted in 2013.